Literature DB >> 17210852

A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors.

Debra A Schaumberg1, Susan E Hankinson, Qun Guo, Eric Rimm, David J Hunter.   

Abstract

OBJECTIVES: To delineate the magnitude of susceptibility to age-related macular degeneration (AMD) due to common variants in the gene for complement factor H (CFH) and the predicted gene LOC387715 and to determine whether these variants interact with modifiable risk factors.
METHODS: We compared cases who developed AMD (n = 457) with 1071 age- and sex-matched control subjects in a prospective nested case-control study within the Nurses' Health Study and the Health Professionals Follow-up Study. We determined the incidence rate ratios and 95% confidence intervals (CIs) for AMD for each genotype and examined the interactions with modifiable risk factors.
RESULTS: Participants with 1 or 2 copies of the Y402H variant of CFH were, respectively, 1.98 (95% CI, 1.64-2.40) and 3.92 (95% CI, 2.69-5.76) times more likely to develop AMD, whereas the incident rate ratios (95% CIs) for 1 and 2 copies of LOC387715 A69S were 2.38 (1.92-2.96) and 5.66 (3.69-8.76), respectively. The fraction of AMD cases attributable to these 2 variants was 63% (95% CI, 58%-68%). Subjects homozygous for both risk alleles had a 50-fold increased risk of AMD (95% CI, 10.8-237), and cigarette smoking and obesity multiplied the risks associated with these variants.
CONCLUSION: Age-related macular degeneration has emerged as a paradigmatic example of a common disease caused by the interplay of genetic predisposition and exposure to modifiable risk factors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17210852     DOI: 10.1001/archopht.125.1.55

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  72 in total

Review 1.  Age-related macular degeneration: genetic and environmental factors of disease.

Authors:  Yuhong Chen; Matthew Bedell; Kang Zhang
Journal:  Mol Interv       Date:  2010-10

Review 2.  [Genetic and risk factors for exudative AMD].

Authors:  M Dietzel; A Farwick; H-W Hense
Journal:  Ophthalmologe       Date:  2010-12       Impact factor: 1.059

3.  Bringing the genetics of macular degeneration into focus.

Authors:  Jonathan L Haines; Kylee M Spencer; Margaret A Pericak-Vance
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-16       Impact factor: 11.205

Review 4.  Lifestyle exposures and eye diseases in adults.

Authors:  Barbara E K Klein; Ronald Klein
Journal:  Am J Ophthalmol       Date:  2007-10-18       Impact factor: 5.258

Review 5.  Progress in defining the molecular biology of age related macular degeneration.

Authors:  Andrew Lotery; Dorothy Trump
Journal:  Hum Genet       Date:  2007-07-21       Impact factor: 4.132

Review 6.  Management of obesity in the elderly: too much and too late?

Authors:  R L Kennedy; U Malabu; M Kazi; V Shahsidhar
Journal:  J Nutr Health Aging       Date:  2008-11       Impact factor: 4.075

Review 7.  The molecular genetic basis of age-related macular degeneration: an overview.

Authors:  Saritha Katta; Inderjeet Kaur; Subhabrata Chakrabarti
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

8.  Prospective study of common variants in CX3CR1 and risk of macular degeneration: pooled analysis from 5 long-term studies.

Authors:  Debra A Schaumberg; Lynda Rose; Margaret M DeAngelis; Richard D Semba; Gregory S Hageman; Daniel I Chasman
Journal:  JAMA Ophthalmol       Date:  2014-01       Impact factor: 7.389

9.  Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort.

Authors:  Jie Jin Wang; Elena Rochtchina; Wayne Smith; Ronald Klein; Barbara E K Klein; Tripti Joshi; Theru A Sivakumaran; Sudha Iyengar; Paul Mitchell
Journal:  Am J Epidemiol       Date:  2008-12-13       Impact factor: 4.897

10.  Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degeneration: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Chelsea E Myers; Stacy M Meuer; Ronald E Gangnon; Theru A Sivakumaran; Sudha K Iyengar; Kristine E Lee; Barbara E K Klein
Journal:  JAMA Ophthalmol       Date:  2013-03       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.